INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,665 | -70.1% | 6,197 | -61.7% | 0.00% | – |
| Q2 2023 | $8,906 | -81.7% | 16,163 | -78.0% | 0.00% | – |
| Q1 2023 | $48,659 | +140.0% | 73,615 | +128.7% | 0.00% | – |
| Q4 2022 | $20,276 | -91.2% | 32,184 | -32.4% | 0.00% | – |
| Q3 2022 | $231,000 | +52.0% | 47,626 | +44.8% | 0.00% | – |
| Q2 2022 | $152,000 | -53.2% | 32,901 | +8.8% | 0.00% | – |
| Q1 2022 | $325,000 | -43.7% | 30,245 | -10.3% | 0.00% | – |
| Q4 2021 | $577,000 | +215.3% | 33,725 | +228.7% | 0.00% | – |
| Q3 2021 | $183,000 | -8.5% | 10,260 | -0.9% | 0.00% | – |
| Q2 2021 | $200,000 | – | 10,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |